Taken together, these data reveal an essential role for Phillyrin in restoring IL-6-linked excessive basal lipolysis and indicate a potential for targeting IL-6/ATGL signaling to combat metabolically unhealthy obesity. This evidence concerns the gene PNPLA2 and obesity due to melanocortin 4 receptor deficiency.